Stefan Schreiber
Goethe University Frankfurt(DE)Kielce University of Technology(PL)Hebrew University of Jerusalem(IL)Christian-Albrechts-Universität zu Kiel(DE)Kiel University(DE)Universitätsklinikum des Saarlandes(DE)University Hospital Schleswig-Holstein(DE)Institute of Solid Mechanics(RO)Clinical Research Center Kiel(DE)University of Lübeck(DE)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease(2012)4,803 cited
- → Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial(2002)4,145 cited
- → Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology(2005)3,360 cited
- → Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci(2010)2,560 cited
- → Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial(2006)2,237 cited
- → Transcriptome and genome sequencing uncovers functional variation in humans(2013)